(Q40217236)

English

Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells.

scientific article published on 12 October 2006

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

title

Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

0 references

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Elvira Crescenzi

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

author name string

Chiara Laezza

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

Simona Pisanti

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

language of work or name

English

0 references

publication date

12 October 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

volume

580

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

issue

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 December 2019

page(s)

6076-6082

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17055492

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17055492%20AND%20SRC:MED&resulttype=core&format=json

(Q40217236)

Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)